Rani Therapeutics (RANI)
(Delayed Data from NSDQ)
$2.26 USD
-0.15 (-6.22%)
Updated Aug 9, 2024 03:59 PM ET
After-Market: $2.26 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Rani Therapeutics Holdings, Inc. [RANI]
Reports for Purchase
Showing records 41 - 46 ( 46 total )
Company: Rani Therapeutics Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Positive Part 1 Results from Ph1 Trial for RT-102 Osteoporosis; Q2 Financials
Provider: Wedbush Securities Inc.
Analyst: ARGYRIDES A
Company: Rani Therapeutics Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Company: Rani Therapeutics Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Delivering Historically Injectable Drugs Orally; Initiate at Buy With $22 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Rani Therapeutics Holdings, Inc.
Industry: Medical - Biomedical and Genetics
E.N.D.O - Exploring New Drug Opportunities in Endocrinology KOL Call Highlights
Provider: Wedbush Securities Inc.
Analyst: ARGYRIDES A
Company: Rani Therapeutics Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Company: Rani Therapeutics Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Eureka! Making Oral Biologics a Reality with RaniPill; Initiating OP & $28 PT
Provider: Wedbush Securities Inc.
Analyst: ARGYRIDES A